Antiretroviral concentrations in small hair samples as a feasible marker of adherence in rural Kenya - PubMed (original) (raw)

. 2014 Jul 1;66(3):311-5.

doi: 10.1097/QAI.0000000000000154.

Charles R Salmen, Robert A Tessler, Dan Omollo, Peter Bacchetti, Richard Magerenge, Brian Mattah, Marcus R Salmen, Daniel Zoughbie, Kathryn J Fiorella, Elvin Geng, Betty Njoroge, Chengshi Jin, Yong Huang, Elizabeth A Bukusi, Craig R Cohen, Monica Gandhi

Affiliations

Antiretroviral concentrations in small hair samples as a feasible marker of adherence in rural Kenya

Matthew D Hickey et al. J Acquir Immune Defic Syndr. 2014.

Erratum in

Abstract

Antiretroviral hair levels objectively quantify drug exposure over time and predict virologic responses. We assessed the acceptability and feasibility of collecting small hair samples in a rural Kenyan cohort. Ninety-five percentage of participants (354/373) donated hair. Although median self-reported adherence was 100% (interquartile range, 96%-100%), a wide range of hair concentrations likely indicates overestimation of self-reported adherence and the advantages of a pharmacologic adherence measure. Higher nevirapine hair concentrations observed in women and older adults require further study to unravel behavioral versus pharmacokinetic contributors. In resource-limited settings, hair antiretroviral levels may serve as a low-cost quantitative biomarker of adherence.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest and Sources of funding: This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH) (RO1 AI098472 to M.G.), a Clinical Research Fellowship grant from the Doris Duke Charitable Foundation (MDH) and a UCSF School of Medicine Dean’s research fellowship (CRS). Additional funding support was provided to the Organic Health Response and Microclinic International by the Google Tides Foundation, the Mulago Foundation and Professor Ray Lifchez of UC Berkeley. For the remaining authors, none were declared.

References

    1. van Zyl GU, van Mens TE, McIlleron H, et al. Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting. J Acquir Immune Defic Syndr. 2011;56(4):333–339. -PMC -PubMed
    1. Fabbiani M, Di Giambenedetto S, Bracciale L, et al. Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice. The Journal of Antimicrobial Chemotherapy. 2009 Jul;64(1):109–117. -PubMed
    1. Li JZ, Gallien S, Ribaudo H, Heisey A, Bangsberg DR, Kuritzkes DR. Incomplete adherence to antiretroviral therapy is associated with higher levels of residual HIV-1 viremia. AIDS. 2013 Dec 19; -PMC -PubMed
    1. Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006 Dec 1;43 (Suppl 1):S79–87. -PMC -PubMed
    1. Kagee A, Nel A. Assessing the association between self-report items for HIV pill adherence and biological measures. AIDS Care. 2012;24(11):1448–1452. -PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources